1. World Health Organization, 2015, WHO Global Tuberculosis Report
2015. 2. Kemenkes RI. Riset Kesehatan Dasar (RISKESDAS) 2010. Jakarta : Kemenkes RI; 2010. 3. Depkes RI. Pedoman Nasional Pengendalian Tuberkulosis. Jakarta : Depkes RI; 2011. 4. Permenkes RI. Penanggulangan Tuberkulosis. Jakarta : Kemenkes RI; 2016 5. PDPI. Pedoman Diagnosis Dan Penatalaksanaan Tuberkulosis Di Indonesia, 2006. 6. Vidyasagar R., Guruprasad P., Aithal. Hepatotoxicity Related to Anti- tuberculosis Drugs: Mechanisms and Management. 2013 7. Alwinsyah A., E.N Keliat., Zuhrial Z., dkk Drug Induced Liver Injury Tipe Kolestatis Akibat Rifampisin. 2016 8. Kullack U, et al. Drug-induced Liver Injury: Recent Advances in Diagnosis and Risk Assessment. 2017. 9. Alwi N., Prevalensi TB Paru yang mengalami Hepatitis Imbas OAT dan Faktor Risiko yang berhubungan di RSUP Persahabatan Jakarta dan RSPG Cisarua pada tahun 2012. 2013 10. Jong E, Conradie F, Berhanu R, Black A, John MA, Meintjes G, Menezes C.Consensus statement: Management of drug-induced liver injury in HIV- positive patients treated for TB.2017 11. Y.Yu, M.Yi, Chen C dkk . CSH guidelines for the diagnosis and treatment of drug-induced liver injury.2017